Recettori κ-oppioidi (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Recettori κ-oppioidi" in Italian language version.

refsWebsite

Global rank Italian rank

2^nd place

7^th place

4^th place

9^th place

799^th place

22^nd place

1web.archive.org

1^st place

1^st place

doi.org

dx.doi.org

James IF, Chavkin C, Goldstein A, Selectivity of dynorphin for kappa opioid receptors, in Life Sciences, vol. 31, n. 12-13, 1982, pp. 1331–4, DOI:10.1016/0024-3205(82)90374-5, PMID 6128656.
Mansour A, Fox CA, Akil H, Watson SJ, Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications, in Trends in Neurosciences, vol. 18, n. 1, gennaio 1995, pp. 22–9, DOI:10.1016/0166-2236(95)93946-U, PMID 7535487.
de Costa BR, Rothman RB, Bykov V, Jacobson AE, Rice KC, Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneity, in Journal of Medicinal Chemistry, vol. 32, n. 2, febbraio 1989, pp. 281–3, DOI:10.1021/jm00122a001, PMID 2536435.
Rothman RB, France CP, Bykov V, De Costa BR, Jacobson AE, Woods JH, Rice KC, Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes, in European Journal of Pharmacology, vol. 167, n. 3, agosto 1989, pp. 345–53, DOI:10.1016/0014-2999(89)90443-3, PMID 2553442.
Mansson E, Bare L, Yang D, Isolation of a human kappa opioid receptor cDNA from placenta, in Biochemical and Biophysical Research Communications, vol. 202, n. 3, agosto 1994, pp. 1431–7, DOI:10.1006/bbrc.1994.2091, PMID 8060324.
Jordan BA, Devi LA, G-protein-coupled receptor heterodimerization modulates receptor function, in Nature, vol. 399, n. 6737, giugno 1999, pp. 697–700, DOI:10.1038/21441, PMC 3125690, PMID 10385123.

nih.gov

ncbi.nlm.nih.gov

James IF, Chavkin C, Goldstein A, Selectivity of dynorphin for kappa opioid receptors, in Life Sciences, vol. 31, n. 12-13, 1982, pp. 1331–4, DOI:10.1016/0024-3205(82)90374-5, PMID 6128656.
Mansour A, Fox CA, Akil H, Watson SJ, Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications, in Trends in Neurosciences, vol. 18, n. 1, gennaio 1995, pp. 22–9, DOI:10.1016/0166-2236(95)93946-U, PMID 7535487.
de Costa BR, Rothman RB, Bykov V, Jacobson AE, Rice KC, Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneity, in Journal of Medicinal Chemistry, vol. 32, n. 2, febbraio 1989, pp. 281–3, DOI:10.1021/jm00122a001, PMID 2536435.
Rothman RB, France CP, Bykov V, De Costa BR, Jacobson AE, Woods JH, Rice KC, Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes, in European Journal of Pharmacology, vol. 167, n. 3, agosto 1989, pp. 345–53, DOI:10.1016/0014-2999(89)90443-3, PMID 2553442.
Mansson E, Bare L, Yang D, Isolation of a human kappa opioid receptor cDNA from placenta, in Biochemical and Biophysical Research Communications, vol. 202, n. 3, agosto 1994, pp. 1431–7, DOI:10.1006/bbrc.1994.2091, PMID 8060324.
Jordan BA, Devi LA, G-protein-coupled receptor heterodimerization modulates receptor function, in Nature, vol. 399, n. 6737, giugno 1999, pp. 697–700, DOI:10.1038/21441, PMC 3125690, PMID 10385123.

oadoi.org

James IF, Chavkin C, Goldstein A, Selectivity of dynorphin for kappa opioid receptors, in Life Sciences, vol. 31, n. 12-13, 1982, pp. 1331–4, DOI:10.1016/0024-3205(82)90374-5, PMID 6128656.
Mansour A, Fox CA, Akil H, Watson SJ, Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications, in Trends in Neurosciences, vol. 18, n. 1, gennaio 1995, pp. 22–9, DOI:10.1016/0166-2236(95)93946-U, PMID 7535487.
de Costa BR, Rothman RB, Bykov V, Jacobson AE, Rice KC, Selective and enantiospecific acylation of kappa opioid receptors by (1S,2S)-trans-2-isothiocyanato-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexy l] benzeneacetamide. Demonstration of kappa receptor heterogeneity, in Journal of Medicinal Chemistry, vol. 32, n. 2, febbraio 1989, pp. 281–3, DOI:10.1021/jm00122a001, PMID 2536435.
Rothman RB, France CP, Bykov V, De Costa BR, Jacobson AE, Woods JH, Rice KC, Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypes, in European Journal of Pharmacology, vol. 167, n. 3, agosto 1989, pp. 345–53, DOI:10.1016/0014-2999(89)90443-3, PMID 2553442.
Mansson E, Bare L, Yang D, Isolation of a human kappa opioid receptor cDNA from placenta, in Biochemical and Biophysical Research Communications, vol. 202, n. 3, agosto 1994, pp. 1431–7, DOI:10.1006/bbrc.1994.2091, PMID 8060324.

web.archive.org

Fine PG, Portenoy RK, Chapter 2: The Endogenous Opioid System (PDF), in A Clinical Guide to Opioid Analgesia, McGraw Hill, 2004. URL consultato il 22 ottobre 2016 (archiviato dall'url originale il 19 luglio 2011).